MNPRbenzinga

Monopar Therapeutics Prices $40M Public Offering Of Common Stock Of 798,655 Shares At $23.79/Share; Concurrent Private Placement Of Pre-Funded Warrants To Purchase 882,761 Shares At $23.789/Pre-Funded Warrant

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on December 20, 2024 by benzinga